| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis Imperfecta | 5 | 2024 | 167 | 3.040 |
Why?
|
| Osteoblasts | 3 | 2024 | 166 | 1.260 |
Why?
|
| Intellectual Disability | 5 | 2021 | 1078 | 1.040 |
Why?
|
| SOX9 Transcription Factor | 1 | 2024 | 87 | 0.840 |
Why?
|
| MAP Kinase Signaling System | 2 | 2024 | 324 | 0.810 |
Why?
|
| Osteogenesis | 4 | 2024 | 168 | 0.810 |
Why?
|
| Coat Protein Complex I | 1 | 2021 | 15 | 0.730 |
Why?
|
| Coatomer Protein | 1 | 2021 | 31 | 0.730 |
Why?
|
| Hand Deformities, Congenital | 2 | 2021 | 95 | 0.690 |
Why?
|
| Citrullinemia | 1 | 2020 | 15 | 0.670 |
Why?
|
| Osteoporosis | 1 | 2021 | 140 | 0.660 |
Why?
|
| Cell Differentiation | 4 | 2024 | 2041 | 0.650 |
Why?
|
| Actins | 3 | 2021 | 350 | 0.640 |
Why?
|
| Developmental Disabilities | 3 | 2021 | 734 | 0.640 |
Why?
|
| Bone and Bones | 1 | 2021 | 310 | 0.610 |
Why?
|
| Endocrinology | 1 | 2020 | 135 | 0.580 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 207 | 0.530 |
Why?
|
| Bone Resorption | 1 | 2016 | 52 | 0.520 |
Why?
|
| Mutation, Missense | 2 | 2018 | 932 | 0.500 |
Why?
|
| DNA-Binding Proteins | 4 | 2023 | 2174 | 0.490 |
Why?
|
| Stromal Cells | 3 | 2006 | 313 | 0.470 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 4800 | 0.450 |
Why?
|
| Mutation | 9 | 2024 | 6304 | 0.430 |
Why?
|
| Mice | 10 | 2024 | 19034 | 0.360 |
Why?
|
| Animals | 15 | 2024 | 36527 | 0.350 |
Why?
|
| Artificial Intelligence | 2 | 2025 | 296 | 0.330 |
Why?
|
| Micrognathism | 2 | 2021 | 68 | 0.310 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 2536 | 0.310 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 847 | 0.290 |
Why?
|
| Urethra | 2 | 2025 | 90 | 0.280 |
Why?
|
| Trans-Activators | 2 | 2015 | 839 | 0.280 |
Why?
|
| Arginine | 2 | 2020 | 351 | 0.280 |
Why?
|
| Fractures, Bone | 2 | 2020 | 212 | 0.260 |
Why?
|
| Bone Marrow Cells | 3 | 2005 | 274 | 0.260 |
Why?
|
| Humans | 33 | 2025 | 134037 | 0.250 |
Why?
|
| Posthumous Conception | 1 | 2025 | 4 | 0.250 |
Why?
|
| Sperm Retrieval | 1 | 2025 | 12 | 0.250 |
Why?
|
| Semen Preservation | 1 | 2025 | 10 | 0.250 |
Why?
|
| Lasers, Solid-State | 1 | 2025 | 17 | 0.230 |
Why?
|
| Whole Genome Sequencing | 4 | 2024 | 325 | 0.230 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2025 | 33 | 0.230 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 69 | 0.230 |
Why?
|
| Chromosome Inversion | 1 | 2024 | 76 | 0.220 |
Why?
|
| Amino Acid Transport System y+L | 2 | 2023 | 17 | 0.220 |
Why?
|
| Prostatic Hyperplasia | 1 | 2025 | 118 | 0.220 |
Why?
|
| Membrane Proteins | 3 | 2024 | 1612 | 0.210 |
Why?
|
| NIH 3T3 Cells | 1 | 2023 | 97 | 0.210 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 150 | 0.210 |
Why?
|
| Gene Knock-In Techniques | 1 | 2024 | 127 | 0.210 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2023 | 19 | 0.210 |
Why?
|
| Spermatozoa | 1 | 2025 | 251 | 0.210 |
Why?
|
| Prostatectomy | 1 | 2025 | 357 | 0.210 |
Why?
|
| DNA Helicases | 3 | 2017 | 252 | 0.210 |
Why?
|
| Male | 18 | 2025 | 66024 | 0.200 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 2 | 2023 | 115 | 0.200 |
Why?
|
| Glycine | 1 | 2024 | 173 | 0.200 |
Why?
|
| Water | 1 | 2024 | 198 | 0.200 |
Why?
|
| Endoscopy | 1 | 2025 | 287 | 0.200 |
Why?
|
| Laser Therapy | 1 | 2025 | 227 | 0.200 |
Why?
|
| Receptors, Glycine | 1 | 2022 | 17 | 0.190 |
Why?
|
| Caenorhabditis elegans | 1 | 2023 | 245 | 0.190 |
Why?
|
| Stem Cells | 2 | 2024 | 753 | 0.190 |
Why?
|
| Exome | 4 | 2021 | 1068 | 0.180 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 352 | 0.180 |
Why?
|
| Aniridia | 1 | 2021 | 11 | 0.180 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 82 | 0.180 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 97 | 0.180 |
Why?
|
| Down-Regulation | 1 | 2023 | 719 | 0.180 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 34 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2022 | 3485 | 0.180 |
Why?
|
| Collagen Type I | 1 | 2021 | 130 | 0.180 |
Why?
|
| Transition to Adult Care | 1 | 2023 | 119 | 0.180 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 455 | 0.180 |
Why?
|
| Embryo, Nonmammalian | 1 | 2021 | 151 | 0.170 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 67 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2021 | 1049 | 0.170 |
Why?
|
| Child | 9 | 2023 | 25818 | 0.170 |
Why?
|
| Endoplasmic Reticulum | 1 | 2021 | 230 | 0.170 |
Why?
|
| Carrier Proteins | 2 | 2023 | 1074 | 0.170 |
Why?
|
| Ammonia | 1 | 2020 | 77 | 0.160 |
Why?
|
| Introns | 1 | 2021 | 319 | 0.160 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2019 | 31 | 0.160 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 274 | 0.160 |
Why?
|
| Hypothermia | 1 | 2020 | 62 | 0.160 |
Why?
|
| Genome, Human | 2 | 2024 | 1342 | 0.160 |
Why?
|
| Diphosphonates | 1 | 2019 | 43 | 0.160 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2020 | 42 | 0.160 |
Why?
|
| Transcription Factors | 5 | 2023 | 2729 | 0.160 |
Why?
|
| Proteomics | 1 | 2023 | 598 | 0.160 |
Why?
|
| Diet, Protein-Restricted | 1 | 2020 | 82 | 0.150 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 721 | 0.150 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 427 | 0.150 |
Why?
|
| Carboxypeptidases | 1 | 2018 | 20 | 0.150 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2024 | 558 | 0.150 |
Why?
|
| Mediator Complex | 1 | 2019 | 56 | 0.150 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2022 | 532 | 0.150 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2018 | 64 | 0.150 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2018 | 13 | 0.150 |
Why?
|
| Zebrafish | 1 | 2021 | 419 | 0.150 |
Why?
|
| Exons | 2 | 2020 | 835 | 0.150 |
Why?
|
| Abnormalities, Multiple | 2 | 2021 | 976 | 0.150 |
Why?
|
| Protein Binding | 2 | 2017 | 1857 | 0.150 |
Why?
|
| Peripheral Nerves | 1 | 2018 | 95 | 0.150 |
Why?
|
| Amino Acid Substitution | 1 | 2019 | 413 | 0.150 |
Why?
|
| Autistic Disorder | 1 | 2022 | 371 | 0.150 |
Why?
|
| Infant, Newborn | 7 | 2020 | 8600 | 0.150 |
Why?
|
| Multiple Carboxylase Deficiency | 1 | 2018 | 3 | 0.140 |
Why?
|
| Heterozygote | 2 | 2017 | 721 | 0.140 |
Why?
|
| Neonatal Screening | 2 | 2017 | 193 | 0.140 |
Why?
|
| Cell Survival | 3 | 2025 | 890 | 0.140 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2018 | 26 | 0.140 |
Why?
|
| Spine | 1 | 2018 | 147 | 0.140 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2017 | 6 | 0.140 |
Why?
|
| Motor Neurons | 1 | 2018 | 157 | 0.140 |
Why?
|
| Female | 13 | 2024 | 71822 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2023 | 4928 | 0.140 |
Why?
|
| Homocystinuria | 1 | 2017 | 27 | 0.140 |
Why?
|
| Drosophila | 1 | 2022 | 829 | 0.140 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2017 | 45 | 0.130 |
Why?
|
| Purkinje Cells | 1 | 2018 | 166 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 407 | 0.130 |
Why?
|
| Anabolic Agents | 1 | 2016 | 15 | 0.130 |
Why?
|
| Fibroblasts | 1 | 2021 | 922 | 0.130 |
Why?
|
| Cell Transplantation | 1 | 2016 | 45 | 0.130 |
Why?
|
| Child, Preschool | 7 | 2021 | 14819 | 0.130 |
Why?
|
| Biological Therapy | 1 | 2016 | 24 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 124 | 0.130 |
Why?
|
| Soluble Guanylyl Cyclase | 1 | 2016 | 7 | 0.130 |
Why?
|
| Drug Therapy | 1 | 2016 | 94 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 219 | 0.120 |
Why?
|
| Phenotype | 6 | 2023 | 4554 | 0.120 |
Why?
|
| Lung | 1 | 2024 | 1575 | 0.120 |
Why?
|
| Brain | 2 | 2021 | 3227 | 0.120 |
Why?
|
| Face | 1 | 2017 | 189 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 625 | 0.120 |
Why?
|
| DNA, Ribosomal | 1 | 2015 | 57 | 0.120 |
Why?
|
| Moyamoya Disease | 1 | 2016 | 42 | 0.120 |
Why?
|
| Esophageal Achalasia | 1 | 2016 | 44 | 0.120 |
Why?
|
| Seizures | 1 | 2020 | 890 | 0.110 |
Why?
|
| Cerebellum | 1 | 2018 | 464 | 0.110 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2016 | 181 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2017 | 423 | 0.110 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1976 | 0.110 |
Why?
|
| Echoencephalography | 1 | 2014 | 26 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2017 | 453 | 0.100 |
Why?
|
| Disease Management | 1 | 2017 | 564 | 0.100 |
Why?
|
| Genetic Testing | 2 | 2018 | 1095 | 0.100 |
Why?
|
| Kidney | 1 | 2020 | 1421 | 0.100 |
Why?
|
| Albuterol | 1 | 2013 | 52 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 3103 | 0.100 |
Why?
|
| Proteoglycans | 2 | 2005 | 94 | 0.100 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2013 | 64 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2016 | 490 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2025 | 3182 | 0.100 |
Why?
|
| Drug Overdose | 1 | 2013 | 75 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 1019 | 0.090 |
Why?
|
| Genetic Therapy | 1 | 2016 | 737 | 0.090 |
Why?
|
| White Matter | 1 | 2014 | 210 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 1343 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2017 | 1619 | 0.080 |
Why?
|
| Adolescent | 6 | 2019 | 20581 | 0.080 |
Why?
|
| Young Adult | 5 | 2025 | 9912 | 0.080 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17506 | 0.070 |
Why?
|
| Infant, Premature | 1 | 2014 | 858 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2021 | 840 | 0.070 |
Why?
|
| Biglycan | 2 | 2005 | 7 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3853 | 0.070 |
Why?
|
| Antigens, Surface | 2 | 2005 | 119 | 0.070 |
Why?
|
| Hypertension | 1 | 2016 | 1397 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2005 | 161 | 0.060 |
Why?
|
| Amino Acids | 2 | 2020 | 687 | 0.060 |
Why?
|
| Infant | 6 | 2018 | 13182 | 0.060 |
Why?
|
| Refrigeration | 1 | 2025 | 10 | 0.060 |
Why?
|
| Adult | 7 | 2025 | 31959 | 0.060 |
Why?
|
| Semen Analysis | 1 | 2025 | 33 | 0.060 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2006 | 128 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2025 | 76 | 0.060 |
Why?
|
| Integrin-Binding Sialoprotein | 1 | 2005 | 2 | 0.060 |
Why?
|
| Bone Matrix | 1 | 2005 | 8 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 48 | 0.060 |
Why?
|
| Steroids | 1 | 2006 | 213 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2025 | 92 | 0.060 |
Why?
|
| Osteocalcin | 1 | 2005 | 50 | 0.060 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 104 | 0.060 |
Why?
|
| Osteopontin | 1 | 2005 | 54 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2024 | 75 | 0.060 |
Why?
|
| Alleles | 2 | 2021 | 1709 | 0.060 |
Why?
|
| Hyaluronan Receptors | 2 | 2002 | 69 | 0.050 |
Why?
|
| HMGB1 Protein | 1 | 2024 | 27 | 0.050 |
Why?
|
| Therapeutic Irrigation | 1 | 2024 | 43 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2024 | 74 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2005 | 361 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2023 | 4005 | 0.050 |
Why?
|
| Biological Variation, Population | 1 | 2023 | 25 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2018 | 5206 | 0.050 |
Why?
|
| Cystectomy | 1 | 2024 | 164 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2005 | 255 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 2664 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2006 | 3181 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1764 | 0.050 |
Why?
|
| Genotype | 2 | 2019 | 2806 | 0.050 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2023 | 158 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2023 | 224 | 0.050 |
Why?
|
| Facies | 1 | 2021 | 154 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2021 | 109 | 0.040 |
Why?
|
| DNA | 1 | 2006 | 1680 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 95 | 0.040 |
Why?
|
| Machine Learning | 1 | 2023 | 339 | 0.040 |
Why?
|
| Cell Line | 1 | 2005 | 2858 | 0.040 |
Why?
|
| Rats | 1 | 2006 | 3890 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 2299 | 0.040 |
Why?
|
| Serine-Type D-Ala-D-Ala Carboxypeptidase | 1 | 2018 | 4 | 0.040 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2019 | 176 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2019 | 253 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 199 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 541 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 188 | 0.040 |
Why?
|
| Osteosarcoma | 1 | 2001 | 264 | 0.040 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2018 | 71 | 0.030 |
Why?
|
| Hydroxocobalamin | 1 | 2017 | 9 | 0.030 |
Why?
|
| Middle Aged | 3 | 2025 | 29394 | 0.030 |
Why?
|
| Carnitine | 1 | 2018 | 78 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 1315 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2019 | 538 | 0.030 |
Why?
|
| Colon | 1 | 2019 | 379 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 383 | 0.030 |
Why?
|
| Sf9 Cells | 1 | 2016 | 10 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 3796 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2016 | 53 | 0.030 |
Why?
|
| Algorithms | 1 | 2023 | 1736 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2001 | 447 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2016 | 197 | 0.030 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 1 | 2015 | 5 | 0.030 |
Why?
|
| Genes, rRNA | 1 | 2015 | 19 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 21750 | 0.030 |
Why?
|
| RNA Polymerase I | 1 | 2015 | 11 | 0.030 |
Why?
|
| Cell Nucleolus | 1 | 2015 | 51 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2016 | 276 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 561 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 289 | 0.030 |
Why?
|
| COS Cells | 1 | 2015 | 284 | 0.030 |
Why?
|
| Time Factors | 1 | 2025 | 6604 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2016 | 395 | 0.030 |
Why?
|
| Peptides | 1 | 2018 | 861 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 632 | 0.030 |
Why?
|
| Ribosomes | 1 | 2015 | 141 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2017 | 592 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 585 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 826 | 0.030 |
Why?
|
| Behavior | 1 | 2014 | 75 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6601 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 4868 | 0.030 |
Why?
|
| Pedigree | 1 | 2017 | 1698 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2015 | 370 | 0.030 |
Why?
|
| Hypokalemia | 1 | 2013 | 41 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 3998 | 0.030 |
Why?
|
| Chromatin | 1 | 2015 | 615 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2002 | 60 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2013 | 242 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2013 | 727 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5475 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 3431 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 1878 | 0.020 |
Why?
|
| Integrin alphaV | 1 | 2002 | 3 | 0.010 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2002 | 18 | 0.010 |
Why?
|
| L-Selectin | 1 | 2002 | 22 | 0.010 |
Why?
|
| Integrin beta3 | 1 | 2002 | 29 | 0.010 |
Why?
|
| S Phase | 1 | 2002 | 78 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2002 | 111 | 0.010 |
Why?
|
| G1 Phase | 1 | 2002 | 67 | 0.010 |
Why?
|
| P-Selectin | 1 | 2002 | 80 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 2002 | 59 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 367 | 0.010 |
Why?
|
| Osteoma, Osteoid | 1 | 2001 | 5 | 0.010 |
Why?
|
| United States | 1 | 2016 | 11752 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 336 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 774 | 0.010 |
Why?
|
| Mitosis | 1 | 2001 | 205 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2001 | 251 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 837 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 1106 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2001 | 2911 | 0.010 |
Why?
|